Analyst Price Targets — QSI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 14, 2026 1:24 pm | Scott Henry | Industrial Alliance Securities | $1.90 | $0.72 | TheFly | Quantum-Si price target lowered to $1.90 from $2.50 at Alliance Global |
| March 4, 2026 11:46 am | Kyle Mikson | Canaccord Genuity | $1.00 | $0.94 | StreetInsider | Quantum-SI Inc. (QSI) PT Lowered to $1 at Canaccord |
| December 22, 2025 11:59 am | — | Canaccord Genuity | $1.50 | $1.27 | TheFly | Quantum-Si price target lowered to $1.50 from $2 at Canaccord |
| October 27, 2025 10:47 am | — | Canaccord Genuity | $2.00 | $2.29 | TheFly | Quantum-Si price target raised to $2 from $1 at Canaccord |
| March 5, 2025 12:19 pm | — | National Bank | $3.65 | $1.40 | TheFly | Quantum-Si price target lowered to $3.65 from $3.75 at Alliance Global Partners |
Latest News for QSI
BRANFORD, Conn., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced that it will be participating in the H.C.
Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript
Quantum-Si NASDAQ: QSI said it has moved the planned launch of its Proteus protein sequencing platform to the second quarter of 2027 from the end of 2026, citing the need for an additional integrated instrument design cycle before production. The company also announced a targeted workforce reduction of about 20% as it seeks to lower cash burn and fund the revised development timeline.
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.16 per share a year ago.
Company updates anticipated commercial launch of Proteus to Q2 2027, cost-reduction actions expected to extend cash runway into Q4 2028 and highlights estimated new market opportunities for protein sequencing BRANFORD, Conn., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for QSI.
U.S. House Trading
No House trades found for QSI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.